Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.

Makiguchi T, Tanaka H, Morikawa K, Hirata A, Itani H, Tanzawa S, Watanabe K, Yasuda H, Horiuchi K, Nakagawa H, Seki Y, Nakahara Y, Hayashi K, Takahashi N, Endo T, Bessho A, Okano T, Takeyama K, Kawase A, Endo M, Maekura T, Nemoto K, Takigawa N, Kishi K, Soejima K, Okuma Y, Togashi A, Matsutani N, Shinchi H, Ueda K, Seki N

Open source

DOI: 10.1016/j.ctarc.2025.100952
Published: 2025
Container: Cancer treatment and research communications
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2025.100952,
  title = {Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.},
  author = {Makiguchi T and Tanaka H and Morikawa K and Hirata A and Itani H and Tanzawa S and Watanabe K and Yasuda H and Horiuchi K and Nakagawa H and Seki Y and Nakahara Y and Hayashi K and Takahashi N and Endo T and Bessho A and Okano T and Takeyama K and Kawase A and Endo M and Maekura T and Nemoto K and Takigawa N and Kishi K and Soejima K and Okuma Y and Togashi A and Matsutani N and Shinchi H and Ueda K and Seki N},
  year = {2025},
  journal = {Cancer treatment and research communications},
  doi = {10.1016/j.ctarc.2025.100952},
  url = {https://doi.org/10.1016/j.ctarc.2025.100952}
}

RIS

TY  - JOUR
TI  - Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.
AU  - Makiguchi T
AU  - Tanaka H
AU  - Morikawa K
AU  - Hirata A
AU  - Itani H
AU  - Tanzawa S
AU  - Watanabe K
AU  - Yasuda H
AU  - Horiuchi K
AU  - Nakagawa H
AU  - Seki Y
AU  - Nakahara Y
AU  - Hayashi K
AU  - Takahashi N
AU  - Endo T
AU  - Bessho A
AU  - Okano T
AU  - Takeyama K
AU  - Kawase A
AU  - Endo M
AU  - Maekura T
AU  - Nemoto K
AU  - Takigawa N
AU  - Kishi K
AU  - Soejima K
AU  - Okuma Y
AU  - Togashi A
AU  - Matsutani N
AU  - Shinchi H
AU  - Ueda K
AU  - Seki N
PY  - 2025
JO  - Cancer treatment and research communications
DO  - 10.1016/j.ctarc.2025.100952
UR  - https://doi.org/10.1016/j.ctarc.2025.100952
ER  -

APA

T, M., H, T., K, M., A, H., H, I., S, T., K, W., H, Y., K, H., H, N., Y, S., Y, N., K, H., N, T., T, E., A, B., T, O., K, T., A, K., M, E., T, M., K, N., N, T., K, K., K, S., Y, O., A, T., N, M., H, S., K, U., & N, S. (2025). Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2025.100952

Source records

pubmed · retrieved 2026-09-26T02:58:46.292Z